Covid in 2021: Innovating To Create a Better Future

march, 2021

2021sat06mar10:00 amsat1:00 pmCovid in 2021: Innovating To Create a Better FutureA future promise to help us increase the quality of life and ultimately get us back to life pre-pandemic.10:00 am - 1:00 pm EST Virtual Conference

Event Details

COVID in 2021: Innovating To Create a Better Future
A future promise to help us increase the quality of life and ultimately get us back to life pre-pandemic.

 

The COVID-19 pandemic has disrupted every aspect of life, from healthcare and biotechnology to the ways in which we work and interact with others. Join OPEN Boston for an engaging virtual conference featuring experts in medicine, disease control, and the healthcare industry, as we explore how to return to pre-pandemic life in 2021.
Confirmed speakers include:
Dr. Nahid Bhadelia, MD, MALD, Infectious Diseases Physician & Medical Director, Special Pathogens Unit at Boston Medical Center
Dr. Fauzia Khan, MD, FCAP, Co-founder, Chief Medical Officer, & Chief Operating Officer of Persivia
Amar Kumar Founder of kaiPod Learning and Former Chief Product Officer of Pearson

 

Agenda:

⏲️10:00 AM – 10:10 AM: Welcome note by OPEN Boston’s President
⏲️10:10 AM – 11:00 AM: Vaccines, Variants, and the Return to Normalcy by Dr. Nahid Bhadelia
⏲️11:00 AM – 12:00 PM: The critical role of AI in COVID detection by Dr. Fauzia Khan
⏲️12:00 PM – 12:30 PM: How COVID has accelerated and scaled Edtech innovation by Amar Kumar
⏲️12:30 PM – 1:00 PM: Closing note by OPEN Boston’s President

 

Here’s a sneak peek at three sessions we’re looking forward to during the conference.
1. Vaccines, Variants and the Return to Normalcy
There’s a whole lot of confusion going around about COVID vaccines, and it needn’t be that way. Let’s understand in what context variants of the COVID vaccines exist and how does the distribution of vaccines looks like.
Featuring:
Dr. Nahid Bhadelia. MD, MALD – Infectious Disease Infectious Diseases Physician & Medical Director, Special Pathogens Unit at Boston Medical Center
2. The Critical role of AI in COVID Detection
AI is more than just gadgets and machines, it’s a technology that gives us the power to change lives–even save lives. Let’s dive into the detection of covid-19 through AI and the technological breakthroughs that will help us better detect, treat, prevent, and beat other major diseases.
Featuring:
Dr. Fauzia Khan – MD, FCAP Co-Founder, CMO, and COO of Persivia.
3. How COVID has accelerated and scaled Edtech Innovation 
The pace of innovation in Edtech during the COVID era has been tightening fast. What does it take to accelerate innovation in EdTech? Let’s examine the changing landscape and see how startups are contributing to it.
Featuring:
Amar Kumar – Founder KaiPod Learning and Former Chief Product Officer of Pearson
Date: March 6th, 2021
Time: 10:00am – 1pm EST

COVID in 2021: Innovating to create a better future - Introduction

How COVID has accelerated and scaled Edtech Innovation by Amar Kumar

The critical role of AI in COVID Detection

Vaccines, Variants and the Return to Normalcy

Speakers for this event

  • Amar Kumar

    Amar Kumar

    Founder KaiPod Learning and Former Chief Product Officer of Pearson

    Amar Kumar is an education entrepreneur passionate about making learning more personal, more social, and more engaging. He is the founder of KaiPod Learning, where small group learning from the time of Aristotle is paired with the online learning of today. In his past experience, Amar was the Chief Product Officer for Pearson's Online K-12 division. He has also been a school teacher and a principal at a high-needs rural school in India.

    Founder KaiPod Learning and Former Chief Product Officer of Pearson

  • Dr. Fauzia Khan, MD, FCAP.

    Dr. Fauzia Khan, MD, FCAP.

    Co-founder, Chief Medical Officer (CMO) and Chief Operating Officer (COO) of Persivia

    Fauzia Khan, MD, FCAP, is a healthcare leader, senior executive, and serial entrepreneur experienced in developing and operationalizing cutting-edge, technology-enabled business solutions. Dr. Khan’s experiences extend from running a Health IT portfolio of a $5.3 Billion company to building two successful start-ups in the physician provider area and the Value-Based Care (VBC) market. She is the Co-founder, Chief Medical Officer (CMO), and Chief Operating Officer (COO) of Persivia a rapidly growing Health IT business with clients that range from the US Government, large Hospital Systems to large and small Provider organizations. In her role as COO, she is responsible for company vision, strategy and execution by providing direction and leadership to develop practical and scalable technologies that allow Clinical Decision Support, Artificial Intelligence, and Analytic capabilities to be seamlessly incorporated into clinical workflows to improve outcomes. Dr. Khan was instrumental in developing the company’s emerging technology products including Artificial Intelligence, Home Monitoring, Population Health, and Care Management. She is experienced in leading healthcare IT organizations to achieve success by transforming the business model and working with complex and often remote teams to collaborate to create value and achieve critical goals. Most recently Dr. Khan was CMO of Connected Health, and Chair, Alere Medical Advisory Board. Dr. Khan is responsible for identifying innovative technologies, emerging evidence-based knowledge, and new capabilities that can further advance the company’s growth. Dr. Khan is the recipient of several awards including Entrepreneur of the Year: High Tech Business from the Immigration Learning Center in 2014 and 2012 Outstanding 50 Asian Americans in Business Award. She is a leading voice for the evolution of population health and chronic care management and has redefined predictive models for risk-bearing entities such as the ACOs to identify and close clinical and financial care gaps. She is also a well-respected thought leader on the topics of patient engagement, population health management, and improved outcomes through adopting new technologies that integrate across the continuum of care, and has published several articles in US News & World Report, HISTalk, Becker’s Hospital Review, and HealthIT Analytics. Dr. Khan has also provided her industry insights on several high-profile conference panels including the US News & World Report’s Hospital of Tomorrow (HOT) conference, Network for Excellence in Health Innovation (NEHI) Innovation Conference, and the National Accountable Care Organization (ACO) Summit. Prior to Alere Analytics, Dr. Khan was a co-founder of DiagnosisOne which was funded by Edison Ventures and was acquired by Alere in a very successful exit in mid-2012. Prior to DiagnosisOne, she was an attending physician, and program director of Informatics, Department of Pathology at UMass Memorial Health Center, and an Assistant Clinical Professor and Director of Clinical Pathology Residency Program at UMass Medical School. She is also an author and chief editor of “Guide to Diagnostic Testing” a textbook on diagnostic algorithms published by Lippincott, Williams, and Wilkins.

    Press Releases:

    The New Normal: Rethinking Healthcare Delivery in a Post-COVID World
    When Public Health Meets Population Health
    It’s Not Enough to Test for Covid-19. We Need To Act on The Data, And fast
    Artificial Intelligence tool Can Spot Possible Coronavirus Cases Before A Test

    Co-founder, Chief Medical Officer (CMO) and Chief Operating Officer (COO) of Persivia

  • Dr. Nahid Bhadelia, MD, MALD.

    Dr. Nahid Bhadelia, MD, MALD.

    Infectious Diseases Physician & Medical Director, Special Pathogens Unit at Boston Medical Center

    Dr. Nahid Bhadelia is an infectious diseases physician and the medical director of the Special Pathogens Unit at Boston Medical Center a medical unit designed to care for patients with highly communicable diseases. She is an Associate Professor in the Section of Infectious Diseases at Boston University School of Medicine. She oversees the medical response program for Boston University’s maximum containment biosafety level 4 program at National Emerging Infectious Diseases Laboratories. She has experience with direct patient care, outbreak response, and medical countermeasures research during multiple Ebola Virus Disease outbreaks in West and East Africa. During the West African Ebola epidemic, she served as a clinician in several Ebola treatment units, working with World Health Organization and Partners in Health. She currently is the medical lead of the Department of Defense (DoD) funded viral hemorrhagic fever research center in Uganda, entitled Joint Mobile Emerging Disease Intervention Clinical Capability (JMEDICC) program. She co-directs NIH’s Fogarty International Center-funded research training program in Liberia entitled “Boston University and the University of Liberia Emerging and Epidemic Virus Research” program (BUULEEVR). Her research focuses on the identification of safe and effective clinical interventions and infection control measures related to viral hemorrhagic fevers and other emerging infectious diseases. She has prior and ongoing experience in health system response to pathogens such as H1N1, Zika, Lassa fever, Marburg Virus Disease, and COVID-19 at the state, national, and global levels, including supply chain evaluation, diagnostic positioning, infection control policy development, and healthcare worker training. She serves on the state, national, and interagency groups focused on biodefense priority setting, development of clinical care guidelines, and medical countermeasures research. She has served as a subject matter expert to US Centers for Disease Control and Prevention, Department of Defense, Global Fund to Fight AIDS, Tuberculosis, and Malaria, and World Bank. Dr. Bhadelia is also an Associate Professor at the Institute of Human Security at the Tufts Fletcher School of Law and Diplomacy, where she teaches a course on human security and emerging infectious diseases. She received her Doctorate of Medicine from Tufts University and completed her internal medicine residency and chief residency at Mount Sinai Hospital in New York. Her Infectious Diseases Fellowship was completed at Columbia Presbyterian Hospital.

    Infectious Diseases Physician & Medical Director, Special Pathogens Unit at Boston Medical Center

Join Now
X
X
X
X